Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s ANDA Approvals

Applicant

Active Ingredients

Number

Date Approved

Hikma

Gabapentin, 600 mg & 800 mg tabs.

78-782

7/21/2011

Marksans

Gabapentin, 100 mg, 300 mg & 400 mg caps.

90-007

7/21/2011

Tolmar

Metronidazole 1% gel

90-903

7/21/2011

West-ward

Fludrocortisone acetate,1 mg tab

91-302

7/22/2011

Lupin

Mefenamic acid 250mg caps.

91-322

7/22/2011

Apotex

Famciclovir,125 mg, 250 mg & 500 mg tabs

91-480

7/22/2011

Hospira

Gemcitabine HCl, EQ 200mg,1gm base/vial, inj.

78-339

7/25/2011

Sun Global

Gemcitabine HCl, EQ 200mg,1gm base/vial, inj.

78-433

7/25/2011

Watson

Gemcitabine HCl EQ 200mg,1gm base/vial, inj.

78-759

7/25/2011

Actavis totowa

Gemcitabine HCl EQ 200mg,1gm base/vial, inj.

79-160

7/25/2011

Dr Reddys Labs

Gemcitabine HCl EQ 200mg,1gm base/vial, inj.

91-365

7/25/2011

Accord Hlthcare

Gemcitabine HCl EQ 200mg,1gm, 2gm base/vial, inj.

91-594

7/25/2011

Onco Therapies

Gemcitabine HCl EQ 200mg,1gm, 2gm base/vial, inj.

200-145

7/25/2011

Sun Global

Chlorothiazide HCl EQ 500mg base/vial, inj.

91-546

7/26/2011

Tentative Approvals

Emcure

Zoledronic acid, 4 mg/5 mL inj.

201-783

7/21/2011

Torrent

Escitalopram oxalate, 5 mg tabs.

90-939

7/22/2011

Dr Reddys Labs

Duloxetine HCl,20mg,30mg,60mg tabs.

90-723

7/22/2011

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel